Targeting androgen receptor aberrations in castration-resistant prostate cancer

A Sharp, J Welti, J Blagg, JS de Bono - Clinical Cancer Research, 2016 - AACR
Androgen receptor (AR) splice variants (SV) have been implicated in the development of
metastatic castration-resistant prostate cancer and resistance to AR targeting therapies …
被引用次数：24 相关文章
[HTML] nih.gov

[HTML][HTML] Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer

A Sharp, J Welti, J Blagg, JS de Bono - Clinical cancer research …, 2016 - ncbi.nlm.nih.gov
Androgen receptor (AR) splice variants (SV) have been implicated in the development of
metastatic castration-resistant prostate cancer and resistance to AR targeting therapies …

Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer

A Sharp, J Welti, J Blagg… - … cancer research: an …, 2016 - pubmed.ncbi.nlm.nih.gov
Androgen receptor (AR) splice variants (SV) have been implicated in the development of
metastatic castration-resistant prostate cancer and resistance to AR targeting therapies …

Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer.

A Sharp, J Welti, J Blagg, JS de Bono - 2016 - repository.icr.ac.uk
Androgen receptor (AR) splice variants (SV) have been implicated in the development of
metastatic castration-resistant prostate cancer and resistance to AR targeting therapies …

Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer.

A Sharp, J Welti, J Blagg, JS de Bono - Clinical Cancer Research …, 2016 - europepmc.org
Androgen receptor (AR) splice variants (SV) have been implicated in the development of
metastatic castration-resistant prostate cancer and resistance to AR targeting therapies …

Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer

A Sharp, J Welti, J Blagg… - … cancer research: an …, 2016 - pubmed.ncbi.nlm.nih.gov
Androgen receptor (AR) splice variants (SV) have been implicated in the development of
metastatic castration-resistant prostate cancer and resistance to AR targeting therapies …

Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer.

A Sharp, J Welti, J Blagg, JS de Bono - Clinical Cancer Research …, 2016 - europepmc.org
Androgen receptor (AR) splice variants (SV) have been implicated in the development of
metastatic castration-resistant prostate cancer and resistance to AR targeting therapies …
[PDF] icr.ac.uk

[PDF][PDF] Targeting Androgen Receptor Aberrations in Castration Resistant Prostate Cancer Adam Sharp, Jonathan Welti, Julian Blagg b and Johann S de Bono

NHS Marsden, UK Sutton, TAR Aberrations - repository.icr.ac.uk
Androgen receptor (AR) splice variants (SV) have been implicated in the development of
metastatic castration resistant prostate cancer and resistance to AR targeting therapies …